General Information of the Compound
Compound ID
CP0141029
Compound Name
2-(6-(4-aminoazepan-1-yl)pyrimidin-4-ylamino)thiazole-5-carbonitrile
    Show/Hide
Structure
Formula
C14H17N7S
Molecular Weight
315.406
Canonical SMILES
NC1CCCN(CC1)c1cc(Nc2ncc(s2)C#N)ncn1
    Show/Hide
InChI
InChI=1S/C14H17N7S/c15-7-11-8-17-14(22-11)20-12-6-13(19-9-18-12)21-4-1-2-10(16)3-5-21/h6,8-10H,1-5,16H2,(H,17,18,19,20)
    Show/Hide
InChIKey
BYTKHJNOVNKMAZ-UHFFFAOYSA-N
Physicochemical Property
logP
1.86598
Rotatable Bonds
3
Heavy Atom Count
22
Polar Areas
103.75
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
8
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 21934593
ChEMBL ID
CHEMBL204163
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00864, Vascular endothelial growth factor receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 15 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 9 nM